1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D4051BB799A146B985257C5900741DB1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-innovative-payer-market-research-contracting-and-formulary-research-activities-and-timings
18
19
203.94.196.192
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Managed Care Payer Market Research

Innovative Payer Market Research: Contracting and Formulary Research Activities & Timing and Understanding National, Regional and Government Payers

ID: 5288


Features:

17 Info Graphics

12 Data Graphics

130+ Metrics

7 Narratives


Pages/Slides: 36


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
STUDY OVERVIEW

Private and public payers have a major influence on the biopharmaceutical industry - a large percentage of pharma's top line revenues flow from payers. As the influence of payers continues to increase it has become important for organizations to better understand not only vital contracting and formulary research activities but also what drives decision-making among national, regional and government payers.

Best Practices, LLC conducted this research to help companies identify what market research approaches are most effective for understanding payer contracting research activities & timing as well as formulary research activities & timing to gauge payer perspectives. The study also presents insights around what drives national, regional and government payer decisions.

KEY TOPICS

  • Study Overview
  • Key Findings & Trends
  • Key Trends in managed markets contracting research
  • Key Trends in payer formulary and tracking research
  • Understanding what drives national and regional payer decision-making
  • Understanding what drives government payer decision-making
SAMPLE KEY METRICS
  • Research approaches used to understand contracting decisions for national, regional, government payers and ACOs/IDNs
  • Effectiveness rating of specific research approaches used to understand payer contracting decisions
  • When in the product lifecycle companies first begin employing five market research approaches for understanding payer contracting decisions
  • Research approaches used to understand formulary decisions for national, regional, government payers and ACOs/IDNs
  • Effectiveness rating of specific research approaches used to understand payer formulary decisions
  • When in the product lifecycle companies first begin employing five market research approaches for understanding payer formulary decisions
  • Market research approaches used to understand national payer decision-making
  • Market research approaches used to understand regional payer decision-making
  • Market research approaches used to understand government payer decision-making
SAMPLE KEY FINDINGS

Pricing and Contracting Research Begins at Phase 2 or Earlier for Some:

  • 33% begin pricing research and 24% begin contracting strategy research at Phase 2 or earlier
  • Nearly 30% of companies begin research at or before Phase 3 to explore partnership efforts related to showing better outcomes in a specified patient population

METHODOLOGY

The research employed a data gathering approach that reaps quantitative & qualitative data from 38 payer research leaders. More than half of the participants represent pharma or biotech companies, and another quarter come from medical device companies. Five selected participants were interviewed to add qualitative depth to the study.

Industries Profiled:
Pharmaceutical; Health Care; Insurance; Medical Device; Market Research; Diagnostic; Education; Consumer Products; Communications; Consulting


Companies Profiled:
Abbott Diabetes Care; Abbott Nutrition; AstraZeneca Neuroscience; CDMI; Biomet; Baxter BioScience; GSW; Joerns Healthcare; Indi; Mako Surgical Corp.; Masimo; Walgreens; Medtronic CRDM; Medtronic Neuromodulation; Hobart Innovations; Health Interactions; Xcenda


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.